Ocena kosztów związanych z występowaniem nadciśnienia tętniczego w Polsce

Summary Background The aim of the study was to assess costs related to hypertension in Poland. This analysis was carried out in GP’s centres throughout the country. The time horizon of the analysis was 12 months and a retrospective approach was applied. The direct medical costs of: pharmacological treatment, doctors’ consultations, laboratory and diagnostic tests and hospitalisations were identified and calculated. Indirect costs due to productivity loss were also included in the analysis. The cost assessment questionnaire was used to collect all the data concerning cost components. Results The average cost per hypertensive patient per year was calculated at 1570 PLN. The total burden of hypertension in Poland, estimated on the basis of PENT study population analysis, may reach 14 billion PLN (14 ¥ 10 9